Skip to main content
. Author manuscript; available in PMC: 2009 Dec 21.
Published in final edited form as: Bioorg Med Chem. 2008 Nov 1;16(24):10257–10269. doi: 10.1016/j.bmc.2008.10.046

Figure 2.

Figure 2

Inhibition curve for amide 42 in a mixed-micelle assay with human GV sPLA2. Non-linear regression (hyperbolic) estimated a XI(50) value of 0.003 ± 0.0004. Compound 42 did not inhibit GIVA cPLA2 and GVIA iPLA2 at 0.091 mole fraction.